WHO: Ebola Outbreak Underestimated

The World Health Organization says the ongoing Ebola outbreak may be worse than their official numbers show and notes that it’s still considering the use of several experimental therapies.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

CDC PUBLIC HEALTH IMAGE LIBRARYAs experts continue to grapple with the ongoing Ebola outbreak that’s crippling the West African countries of Guinea, Liberia, and Sierra Leone, the World Health Organization (WHO) is expressing concern that the reported numbers of suspected and confirmed cases of infection “vastly underestimate the magnitude of the outbreak.” In a statement issued last week (August 14), the WHO outlined its outbreak-response objectives, noting that “the outbreak is expected to continue for some time.”

During a Friday press conference, Joanne Liu, international president of Doctors Without Borders, guessed it would take officials around six months to contain the outbreak, Reuters reported.

In the meantime, healthcare officials continue to weigh experimental treatment options as biotech firms developing Ebola drugs that have not yet been tested in the clinic are running out of supplies. In an e-mail to ScienceInsider, the WHO said it is considering administering the blood of people who’ve survived Ebola infection to those who fall ill to the virus. “Convalescent serum is high on our list of potential therapies and has been used in other outbreaks,” the organization told Science.

Still, when treating Ebola-infected patients, “there is not a lot of extra time to experiment with unproven therapies,” ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH